Newman Dignan & Sheerar’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Newman Dignan & Sheerar's LLY Position: Q3 2026 in Review
Newman Dignan & Sheerar held its Eli Lilly (LLY) position steady in Q3 2026 at 1,043 shares worth $1.21M. The position accounts for 0.23% of the portfolio, ranked #80.
Newman Dignan & Sheerar first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.25M in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Newman Dignan & Sheerar held 1,043 shares of Eli Lilly worth $1.21M as of Q3 2026.
- Newman Dignan & Sheerar left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.23% of Newman Dignan & Sheerar's portfolio in Q3 2026, its #80 holding.
- Newman Dignan & Sheerar first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
- Newman Dignan & Sheerar's Eli Lilly position peaked at $1.25M in Q2 2026.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Newman Dignan & Sheerar's 13F filing for Q3 2026, filed 21 Oct 2026.